Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France

BACKGROUND: Injectable opioids are an interesting option for people who inject drugs (PWID) that do not respond to oral Opioid Maintenance Treatment (OMT). To date, intravenous (IV) buprenorphine - a safer drug than full-opioid agonists in terms of overdose risk - has never been tested in a clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Roux, Perrine, Rojas Castro, Daniela, Ndiaye, Khadim, Briand Madrid, Laélia, Laporte, Virginie, Mora, Marion, Maradan, Gwenaelle, Morel, Stéphane, Spire, Bruno, Carrieri, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667450/
https://www.ncbi.nlm.nih.gov/pubmed/29096661
http://dx.doi.org/10.1186/s13011-017-0131-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667450/
https://www.ncbi.nlm.nih.gov/pubmed/29096661
http://dx.doi.org/10.1186/s13011-017-0131-4

Ejemplares similares